Subcutaneous Ketamine for depression
This study is not yet recruiting in Global. It is testing subcutaneous Ketamine for depression.
In Global
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is not yet recruiting in Global. It is testing subcutaneous Ketamine for depression.
In GlobalThis study is not yet recruiting. It focuses on mental health and currently lists study information in France.
Multiple locations, including BordeauxThis study is not yet recruiting. It focuses on ADHD and currently lists study information in France.
Multiple locations, including GrenobleThis study is not yet recruiting. It focuses on anxiety and currently lists study information in Global.
In GlobalThis study is not yet recruiting. It focuses on depression and currently lists study information in Global.
In GlobalThis study is not yet recruiting. It focuses on depression and currently lists study information in Turkey.
In AmasyaThis study is not yet recruiting. It focuses on depression and currently lists study information in Global.
In GlobalThis study is not yet recruiting. It focuses on mental health and currently lists study information in Global.
In GlobalThis study is not yet recruiting. It focuses on depression and currently lists study information in the United States.
In San FranciscoThis study is not yet recruiting. It focuses on PTSD and currently lists study information in the United States.
In San FranciscoThis study is not yet recruiting. It focuses on PTSD and currently lists study information in Global.
In GlobalThis study is not yet recruiting in Taiwan. It is testing Digital Anti-stigma Therapy on Illness Perception and Perceived Stigma for schizophrenia.
In TaipeiHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.